People In The News

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nicholas Naclerio has been named VP of corporate development at Illumina. Naclerio formerly was co-founder and executive chairman of Quanterix. In the new role, he will be responsible for licensing, strategic planning, and acquisitions. He also previously raised money for Boreal Genomics, O-Link Bioscience, and Fluxion Bioscience, and he served as president and CEO of ParAllele BioScience.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.